US OptionsDetailed Quotes
NMRA250117C3500
- 0.10
- +0.05+100.00%
15min DelayClose Jan 6 16:00 ET
0.15High0.05Low
0.05Open0.05Pre Close790 Volume729 Open Interest3.50Strike Price5.89KTurnover194.41%IV45.16%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier10DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type0.1918Delta0.3324Gamma33.07Leverage Ratio-0.0106Theta0.0001Rho6.34Eff Leverage0.0012Vega
Neumora Therapeutics Stock Discussion
The average price target for Neumora Therapeutics, Inc. is $24.17. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $30.00 ,the lowest forecast is $15.00.
H.C. Wainwright reaffirmed its Buy rating and a price target of $30.00 for Neumora Therapeutics (NASDAQ:NMRA) stock.
——-
On Friday, Mizuho (NYSE:MFG) Securities reiterated its Outperform rating on Neumora Therapeutics (NASDAQ:NMRA) with a steady price target of $20.00, despite the company's recent setback with its lead drug candidate, navacaprant.
———-
jp morgan target price 15
Many antidepressants have had at least one Phase 3 failure before winning approval
No comment yet